List of selected publications and research outputs can be listed here with links and short summaries.
We showed that CD34⁺/CD133⁺ UCB cells support persistent DENV infection (up to 30 days) with productive and latent phases, retaining the ability to reactivate and transmit infectious virus.
We provided new insight and evidence that DENV infection can induce HSPC mobilization, also that the mobilized HSPCs were not only permissive to DENV infection, but infectious DENV could be recovered after coculture.
We provide new insights into the potential use of A. cinnamomea extracts as therapeutic agents against DENV infection.
We showed that CD133⁺/CD34⁺ cells in umbilical cord blood may act as viral reservoirs that amplify DENV and contribute to vertical transmission.
In this study, we screened 23 cytokines from 243 patient sera across different dengue disease severities. The results reveal cytokine storm and immune dysregulation, with IL-10 and CD121b as potential biomarkers for diagnosis and disease severity prediction.